The share price of Reata Pharmaceuticals, Inc. (RETA) now
Latest session on the 26th of September for
Reata Pharmaceuticals, Inc. is negative
Trading Volume: 0
Open: 172.36 /
High: 172.36 /
Low: 172.36
What analysts predict: $
52-week High/Low: $ / $
50/200 Day Moving Average:
$ / $
This figure corresponds to the Average Price over the previous 50/200 days.
For Reata Pharmaceuticals stocks, the 50-day moving average is the support level today.
For Reata Pharmaceuticals stocks, the 200-day moving average is the support level today.
Are you interested in Reata Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio?
If yes, then on this page you will find useful information about the dynamics of the Reata Pharmaceuticals
stock price in 2023, 2024, 2025, 2026, 2027.
How much will one Reata Pharmaceuticals share be worth in
2023 - 2027?
When should I take profit in Reata Pharmaceuticals stock?
When should I record a loss on Reata Pharmaceuticals stock?
What are analysts' forecasts for Reata Pharmaceuticals stock?
What is the future of Reata Pharmaceuticals stock?
We forecast Reata Pharmaceuticals stock performance using neural networks based on historical data on Reata Pharmaceuticals stocks.
Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Reata Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals.
(Next month, 2023, 2024, 2025, 2026 and 2027)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Reata Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Reata Pharmaceuticals stock
The chart below shows the historical price of Reata Pharmaceuticals stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Reata Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Reata Pharmaceuticals, Inc., a clinical biopharmaceutical company, is developing new therapies for patients with serious or life-threatening illnesses by targeting molecular pathways that regulate cellular metabolism and inflammation.
Trending Themes in the Healthcare Sector
Reata Pharmaceuticals daily forecast for a month
Date
Target
Pes.
Opt.
Vol., %
Dec 07
177.92
174.98
182.19
4.12
Dec 08
180.50
176.53
184.74
4.65
Dec 09
181.22
175.33
183.58
4.70
Dec 10
173.52
170.22
177.60
4.33
Dec 11
172.13
165.50
176.69
6.76
Dec 12
168.26
161.86
170.70
5.46
Dec 13
170.53
164.82
174.02
5.59
Dec 14
174.45
168.26
176.54
4.92
Dec 15
165.73
161.92
168.55
4.09
Dec 16
163.33
161.61
166.27
2.88
Dec 17
155.73
150.75
158.61
5.22
Dec 18
159.62
157.39
165.53
5.17
Dec 19
167.37
162.01
172.72
6.61
Dec 20
167.78
165.02
172.99
4.83
Dec 21
165.52
161.96
170.15
5.06
Dec 22
165.19
160.98
171.55
6.57
Dec 23
161.22
155.18
163.32
5.25
Dec 24
158.97
155.47
163.50
5.16
Dec 25
151.81
149.08
154.24
3.46
Dec 26
149.54
145.57
153.65
5.55
Dec 27
148.79
145.81
154.37
5.87
Dec 28
151.91
150.39
156.77
4.24
Dec 29
149.86
144.54
153.83
6.43
Dec 30
149.19
145.98
151.28
3.63
Dec 31
153.81
148.81
159.66
7.29
Jan 01
151.66
149.69
154.16
2.99
Jan 02
149.01
146.77
154.07
4.98
Jan 03
142.23
138.31
145.71
5.35
Jan 04
143.15
138.00
145.37
5.34
Jan 05
143.87
140.56
146.46
4.20
Reata Pharmaceuticals Daily Price Targets
Reata Pharmaceuticals Stock Forecast 12-07-2023.
Forecast target price for 12-07-2023: $177.92. Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 3.955%. Pessimistic target level: 174.98 Optimistic target level: 182.19
Reata Pharmaceuticals Stock Forecast 12-08-2023.
Forecast target price for 12-08-2023: $180.50. Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 4.446%. Pessimistic target level: 176.53 Optimistic target level: 184.74
Reata Pharmaceuticals Stock Forecast 12-09-2023.
Forecast target price for 12-09-2023: $181.22. Positive dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 4.492%. Pessimistic target level: 175.33 Optimistic target level: 183.58
Reata Pharmaceuticals Stock Forecast 12-10-2023.
Forecast target price for 12-10-2023: $173.52. Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 4.153%. Pessimistic target level: 170.22 Optimistic target level: 177.60
Reata Pharmaceuticals Stock Forecast 12-11-2023.
Forecast target price for 12-11-2023: $172.13. Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 6.332%. Pessimistic target level: 165.50 Optimistic target level: 176.69
Reata Pharmaceuticals Stock Forecast 12-12-2023.
Forecast target price for 12-12-2023: $168.26. Negative dynamics for Reata Pharmaceuticals shares will prevail with possible volatility of 5.175%. Pessimistic target level: 161.86 Optimistic target level: 170.70
Market capitalization of the Reata Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula
multiplying the number of RETA shares in the company outstanding by the market price of one share.
EBITDA:
N/A $
EBITDA of Reata Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
PE Ratio:
N/A
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio:
N/A
Price/earnings to growth
DPS:
N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY:
N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS:
N/A
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY:
N/A
Quarterly Revenue Growth YOY:
N/A
Trailing PE:
N/A
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE:
N/A
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue:
N/A
Enterprise Value (EV) /Revenue
EV To EBITDA:
N/A
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding:
N/A
Number of issued ordinary shares
Shares Float:
N/A
Number of freely tradable shares
Shares Short Prior Month:
N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and,
moreover, are not trading signals.
When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market
as a result of using the information contained on the site.
This website uses cookies to ensure you get the best experience on our website